skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Nome da Publicação: Pharmacoeconomics & Outcomes News remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
NICE issues new guidance for asthma
Material Type:
Artigo
Adicionar ao Meu Espaço

NICE issues new guidance for asthma

PharmacoEconomics & outcomes news, 2017-12, Vol.793 (1), p.35-35

Cham: Springer International Publishing

Texto completo disponível

2
ADHD imposes substantial economic burden on society
Material Type:
Artigo
Adicionar ao Meu Espaço

ADHD imposes substantial economic burden on society

PharmacoEconomics & outcomes news, 2021, Vol.872 (1), p.2-2

Cham: Springer International Publishing

Texto completo disponível

3
Latest NICE draft guidance does not recommend elusulfase alfa for rare disorder
Material Type:
Artigo
Adicionar ao Meu Espaço

Latest NICE draft guidance does not recommend elusulfase alfa for rare disorder

PharmacoEconomics & outcomes news, 2021, Vol.892 (1), p.32-32

Cham: Springer International Publishing

Texto completo disponível

4
NICE draft guideline on pelvic floor dysfunction
Material Type:
Artigo
Adicionar ao Meu Espaço

NICE draft guideline on pelvic floor dysfunction

PharmacoEconomics & outcomes news, 2021, Vol.882 (1), p.33-33

Cham: Springer International Publishing

Texto completo disponível

5
NICE recommends pembrolizumab for advanced melanoma
Material Type:
Artigo
Adicionar ao Meu Espaço

NICE recommends pembrolizumab for advanced melanoma

PharmacoEconomics & outcomes news, 2015-10, Vol.739 (1), p.35-35

Cham: Springer International Publishing

Texto completo disponível

6
Alvimopan reduces costs in radical cystectomy for bladder cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

Alvimopan reduces costs in radical cystectomy for bladder cancer

PharmacoEconomics & outcomes news, 2020, Vol.851 (1), p.3-3

Cham: Springer International Publishing

Texto completo disponível

7
Influenza vaccination for age 50−64 cost beneficial in Australia
Material Type:
Artigo
Adicionar ao Meu Espaço

Influenza vaccination for age 50−64 cost beneficial in Australia

PharmacoEconomics & outcomes news, 2019, Vol.836 (1), p.15-15

Cham: Springer International Publishing

Texto completo disponível

8
STrAtegies for RelaTives doesn't increase costs of dementia
Material Type:
Artigo
Adicionar ao Meu Espaço

STrAtegies for RelaTives doesn't increase costs of dementia

PharmacoEconomics & outcomes news, 2019, Vol.833 (1), p.31-31

Cham: Springer International Publishing

Texto completo disponível

9
Intrapleural alteplase and domase alfa cost effective
Material Type:
Artigo
Adicionar ao Meu Espaço

Intrapleural alteplase and domase alfa cost effective

PharmacoEconomics & outcomes news, 2019, Vol.829 (1), p.16-16

Cham: Springer International Publishing

Texto completo disponível

10
Bevacizumab less costly, just as safe as ranibizumab in AMD
Material Type:
Artigo
Adicionar ao Meu Espaço

Bevacizumab less costly, just as safe as ranibizumab in AMD

PharmacoEconomics & outcomes news, 2014, Vol.712 (1), p.9-9

Cham: Springer International Publishing

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1)

Buscando em bases de dados remotas. Favor aguardar.